70 results
Page 2 of 4
8-K
EX-1.1
om6bk
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-1.1
vhy9 pcr7
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
424B5
215p8gqfp zmcu
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
dkhnblp42n u0h3t
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
obrp ok818
28 Feb 20
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
10:28am
8-K
EX-99.1
8k25u
11 Feb 20
PEDMARKTM1 is Being Developed for Prevention of Cisplatin-Induced Hearing Loss in Children
2:17pm
8-K
EX-99.1
ao7ov6whrr34gpol
14 Mar 19
Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
6:02am
8-K
EX-10.1
g420xj7
4 Feb 19
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing with Bridge Bank
2:26pm